Predicting mortality in patients with systemic inflammatory response syndrome: An evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 5, 2008, Pages 375-383

  Kofoed, K ^a   Eugen Olsen, J ^a   Petersen, J ^a   Larsen, K ^a   Andersen, O ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MACROPHAGE MIGRATION INHIBITION FACTOR; PLASMINOGEN ACTIVATOR; RECEPTOR PROTEIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MOLECULAR MODEL; MORTALITY; PLASMA; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; ROC CURVE; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 43049104122     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0447-5     Document Type: Article

References (60)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
2. Huang DT (2004) Clinical review: impact of emergency department care on intensive care unit costs. Crit Care 8:498-502
3. Rivers EP, Nguyen HB, Amponsah D (2003) Sepsis: a landscape from the emergency department to the intensive care unit. Crit Care Med 31:968-969
4. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234-240
5. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31:670-675
6. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
7. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
8. Nguyen HB, Rivers EP, Havstad S, Knoblich B, Ressler JA, Muzzin AM, Tomlanovich MC (2000) Critical care in the emergency department: a physiologic assessment and outcome evaluation. Acad Emerg Med 7:1354-1361
9. Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo CA Jr (2006) National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med 48:326-331
10. Anwaruddin S, Askari AT, Topol EJ (2007) Redefining risk in acute coronary syndromes using molecular medicine. J Am Coll Cardiol 49:279-289
11. Bozza FA, Gomes RN, Japiassú AM, Soares M, Castro-Faria-Neto HC, Bozza PT, Bozza MT (2004) Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22:309-313
12. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778
13. Kellett J, Deane B (2006) The Simple Clinical Score predicts mortality for 30 days after admission to an acute medical unit. QJM 99:771-781
14. Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D (2006) The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48:583-590
15. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW (2005) Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45:524-528
16. Chuang CC, Wang ST, Chen WC, Chen CC, Hor LI, Chuang AY (2007) Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality. Shock 27:503-506
17. Gaïni S, Koldkjaer OG, Pedersen C, Pedersen SS (2006) Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 10:R53
18. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stüber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606-618
19. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
20. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710
21. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G (2003) Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 31:2316-2323
22. Vincent JL (2004) Endpoints in sepsis trials: more than just 28-day mortality? Crit Care Med 32:S209-S213
23. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H (2006) Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 10:R166
24. Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE (2004) Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141:9-15
25. Ostergaard C, Benfield T, Lundgren JD, Eugen-Olsen J (2004) Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome. Scand J Infect Dis 36:14-19
26. Perch M, Kofoed P, Fischer TK, Có F, Rombo L, Aaby P, Eugen-Olsen J (2004) Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 26:207-211
27. Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J (2000) Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96:4091-4095
28. Chuang CC, Hung CJ, Tsai MC, Yeh TM, Chuang YC (2004) High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: is serum macrophage migration inhibitory factor concentration a valuable prognostic factor? Crit Care Med 32:734-739
29. Rahman SH, Menon KV, Holmfield JH, McMahon MJ, Guillou JP (2007) Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis. Ann Surg 245:282-289
30. Emonts M, Sweep FC, Grebenchtchikov N, Geurts-Moespot A, Knaup M, Chanson AL, Erard V, Renner P, Hermans PW, Hazelzet JA, Calandra T (2007) Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 44:1321-1328
31. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11:R38
32. Sepsis: Prognosis and Evaluation of Early Diagnosis and Intervention (SPEEDI Study) (2007) Clinical Trials. Home page at http://www.clinicaltrials. gov/ct/show/NCT00389337?order=1
33. Kofoed K, Schneider UV, Scheel T, Andersen O, Eugen-Olsen J (2006) Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin Chem 52:1284-1293
34. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32-35
35. Xiong C, McKeel DW Jr, Miller JP, Morris JC (2004) Combining correlated diagnostic tests: application to neuropathologic diagnosis of Alzheimer's disease. Med Decis Making 24:659-669
36. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843
37. Auriant I, Vinatier I, Thaler F, Tourneur M, Loirat P (1998) Simplified acute physiology score II for measuring severity of illness in intermediate care units. Crit Care Med 26:1368-1371
38. Beck DH, Smith GB, Pappachan JV, Millar B (2003) External validation of the SAPS II, APACHE II and APACHE III prognostic models in South England: a multicentre study. Intensive Care Med 29:249-256
39. Castella X, Artigas A, Bion J, Kari A (1995) A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit Care Med 23:1327-1335
40. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286:1754-1758
41. Junger A, Engel J, Benson M, Böttger S, Grabow C, Hartmann B, Michel A, Röhrig R, Marquardt K, Hempelmann G (2002) Discriminative power on mortality of a modified Sequential Organ Failure Assessment score for complete automatic computation in an operative intensive care unit. Crit Care Med 30:338-342
42. Katsaragakis S, Papadimitropoulos K, Antonakis P, Strergiopoulos S, Konstadoulakis MM, Androulakis G (2000) Comparison of Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) scoring systems in a single Greek intensive care unit. Crit Care Med 28:426-432
43. Moreno R, Apolone G, Miranda DR (1998) Evaluation of the uniformity of fit of general outcome prediction models. Intensive Care Med 24:40-47
44. Nouira S, Belghith M, Elatrous S, Jaafoura M, Ellouzi M, Boujdaria R, Gahbiche M, Bouchoucha S, Abroug F (1998) Predictive value of severity scoring systems: comparison of four models in Tunisian adult intensive care units. Crit Care Med 26:852-859
45. Peres Bota D, Mélot C, Lopes Ferreira F, Nguyen Ba V, Vincent J-L (2002) The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction. Intensive Care Med 28:1619-1624
46. Tan IK (1998) APACHE II and SAPS II are poorly calibrated in a Hong Kong intensive care unit. Ann Acad Med Singapore 27:318-322
47. Ulvik A, Wentzel-Larsen T, Flaatten H (2007) Trauma patients in the intensive care unit: short- and long-term survival and predictors of 30-day mortality. Acta Anaesthesiol Scand 51:171-177
48. Shapiro NI, Howell MD, Talmor D, Donnino M, Ngo L, Bates DW (2007) Mortality in Emergency Department Sepsis (MEDS) score predicts 1-year mortality. Crit Care Med 35:192-198
49. Gando S, Nishihira J, Kobayashi S, Morimoto Y, Nanzaki S, Kemmotsu O (2001) Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 27:1187-1193
50. Lehmann LE, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, Hoeft A, Stüber F (2001) Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 27:1412-1415
51. Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H (2006) Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 97:503-508
52. Heper Y, Akalin EH, Mistik R, Akgöz S, Töre O, Göral G, Oral B, Budak F, Helvaci S (2006) Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25:481-491
53. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488-493
54. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596-2602
55. Bishara J, Hadari N, Shalita-Chesner M, Samra Z, Ofir O, Paul M, Peled N, Pitlik S, Molad Y (2007) Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis 26:647-650
56. Muller B, Gencay MM, Gibot S, Stolz D, Hunziker L, Tamm M, Christ-Crain M (2007) Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia. Crit Care Med 35:990-991
57. Tejera A, Santolaria F, Diez ML, Alemán-Valls MR, González-Reimers E, Martinez-Riera A, Milena-Abril A (2007) Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 38:117-123
58. Fortin CF, Lesur O, Fulop T Jr (2007) Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett 581:1173-1178
59. Mire-Sluis AR, Gaines-Das R, Thorpe R (1995) Immunoassays for detecting cytokines: what are they really measuring? J Immunol Methods 186:157-160
60. Eugen-Olsen J, Stausgaard A, Kahns L, Kyhse-Andersen J, Teversham K (2006) suPARnostic™, a novel and simple assay for monitoring HIV disease progression. In: Abstract and programme of the 16th International AIDS Conference, Toronto, Canada, August 2006, abstract no MoPE0141